Cargando…

Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations

Due to unknown safety concerns, sugammadex should not be administered to patients with end-stage renal disease (ESRD). However, because the supply of benzylisoquinolinium-type neuromuscular blocking agents (NMBAs) has been discontinued, rocuronium is the only non-depolarizing NMBA that can be used i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Seok Kyeong, Lim, Byung Gun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Anesthesiologists 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902629/ https://www.ncbi.nlm.nih.gov/pubmed/36746897 http://dx.doi.org/10.17085/apm.22259

Ejemplares similares

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
por: Kim, Young-Sung, et al.
Publicado: (2021)

Effect of protracted dexamethasone exposure and its withdrawal on rocuronium-induced neuromuscular blockade and sugammadex reversal: an ex vivo rat study
por: Oh, Seok Kyeong, et al.
Publicado: (2019)

Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report-
por: Kim, Gunn Hee, et al.
Publicado: (2019)

Preparing for the unexpected: special considerations and complications after sugammadex administration
por: Iwasaki, Hajime, et al.
Publicado: (2017)

Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
por: Goh, Zhong Sheng, et al.
Publicado: (2018)

Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with End-Stage Renal Disease on Hemodialysis: A Narrative Review
por: Egashira, Shuhei, et al.
Publicado: (2022)

In vitro investigation of the effects of exogenous sugammadex on coagulation in orthopedic surgical patients
por: Lee, Il Ok, et al.
Publicado: (2018)

Postoperative mortality in patients with end-stage renal disease according to the use of sugammadex: a single-center retrospective propensity score matched study
por: Song, Sanghoon, et al.
Publicado: (2022)

Effects of Sugammadex and Neostigmine on Renal Biomarkers
por: Isik, Yasemin, et al.
Publicado: (2016)

Thrombectomy approach for access maintenance in the end stage renal disease population: a narrative review
por: Wu, Vincent, et al.
Publicado: (2021)

In the hour of Sugammadex
por: Chon, Jin Young
Publicado: (2013)

Evaluation of Gastric Emptying by Ultrasonography after Recommended Fasting Period and Administration of Prokinetic in End-stage Renal Disease Patients
por: Gupta, Richa, et al.
Publicado: (2020)

The effect of dexamethasone on sugammadex reversal of rocuronium-induced neuromuscular blockade in surgical patients undergoing general anesthesia: A systematic review and meta-analysis
por: Lim, Byung Gun, et al.
Publicado: (2021)

Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis
por: Won, Young Ju, et al.
Publicado: (2016)

Sugammadex, the Guardian of Deep Muscle Relaxation During Conventional and Robot-Assisted Laparoscopic Surgery: A Narrative Review
por: Sun, Yan, et al.
Publicado: (2021)

Decrease in heart rate following the administration of sugammadex in adults
por: Sims, Trent, et al.
Publicado: (2020)

Assessment of the effects of sugammadex on coagulation profiles using thromboelastographic parameters
por: Kang, Woon-Seok, et al.
Publicado: (2020)

Sugammadex facilitates early recovery after surgery even in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: a single-center retrospective study
por: Park, Eui-Seok, et al.
Publicado: (2016)

Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations
por: Gunawansa, Nalaka, et al.
Publicado: (2018)

Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update
por: El-Zaatari, Ziad M., et al.
Publicado: (2022)

Apolipoprotein B is a risk factor for end-stage renal disease
por: Kwon, Soie, et al.
Publicado: (2020)

Atherosclerotic plaque composition and specific endovascular considerations in the end stage renal disease patients: a narrative review
por: Ruff, Christer, et al.
Publicado: (2022)

Possible mitigation of rocuronium-induced anaphylaxis after administration of sugammadex
por: Motamed, Cyrus, et al.
Publicado: (2012)

Lung ultrasonography in end-stage renal disease: moving from evidence to practice—a narrative review
por: Ross, Daniel W, et al.
Publicado: (2018)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
por: Lee, Seonhwa, et al.
Publicado: (2020)

Catheter-related bloodstream infection in end-stage kidney disease: a Canadian narrative review
por: Lata, Chris, et al.
Publicado: (2016)

Outcomes of Endoscopic Retrograde Cholangiopancreatography in End-Stage Renal Disease Patients Undergoing Hemodialysis: A Systematic Review and Pooled Analysis
por: Park, Tae Young, et al.
Publicado: (2022)

Efficacy and safety of sugammadex in patients undergoing renal transplantation
por: Ono, Yasumasa, et al.
Publicado: (2018)

Author Correction: Assessment of the effects of sugammadex on coagulation profiles using thromboelastographic parameters
por: Kang, Woon-Seok, et al.
Publicado: (2020)

Accidental Intrathecal Administration of Digoxin in an Elderly Male with End-Stage Renal Disease
por: Martin, Claudia, et al.
Publicado: (2017)

Outcomes of open heart surgery in patients with end-stage renal disease
por: Park, Jung Hwa, et al.
Publicado: (2019)

Reversal by Sugammadex
por: Bajaj, Pramila
Publicado: (2009)

Sugammadex-induced anaphylactic reaction: A systematic review
por: Zecic, Fatih, et al.
Publicado: (2022)

Hydrochlorothiazide does not increase furosemide's effects in end-stage renal disease
por: Huh, Wooseong, et al.
Publicado: (2017)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)

Advantages and pitfalls of clinical application of sugammadex
por: Lee, Hyung Young, et al.
Publicado: (2020)

A rare case of atropine-resistant bradycardia following sugammadex administration
por: Yoshida, Takayuki, et al.
Publicado: (2020)

Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient
por: Fierro, Carmen, et al.
Publicado: (2021)

Bradycardia in a pediatric population after sugammadex administration: case series
por: Carvalho, Erica Viviana Guimarães, et al.
Publicado: (2022)

Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6k1ugtfboqfgdks0j41q5qthgr